{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:48:44Z","timestamp":1776919724188,"version":"3.51.2"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"National Major Scientific and Technological Special Project of China","award":["2009ZX09103709"],"award-info":[{"award-number":["2009ZX09103709"]}]},{"name":"National Major Scientific and Technological Special Project of China","award":["2013ZX09102057"],"award-info":[{"award-number":["2013ZX09102057"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.biopha.2017.06.047","type":"journal-article","created":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T04:04:48Z","timestamp":1498277088000},"page":"334-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["MicroRNA-493 suppresses hepatocellular carcinoma tumorigenesis through down-regulation of anthrax toxin receptor 1 (ANTXR1) and R-Spondin 2 (RSPO2)"],"prefix":"10.1016","volume":"93","author":[{"given":"Yuqiang","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuikui","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingshan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biopha.2017.06.047_bib0005","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"El-Serag","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.biopha.2017.06.047_bib0010","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ccr.2011.11.021","article-title":"Targeting liver cancer: first steps toward a miRacle?","volume":"20","author":"Schwabe","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2017.06.047_bib0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev.med.080608.100623","article-title":"Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy","volume":"61","author":"Villanueva","year":"2010","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.biopha.2017.06.047_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/13651820410024049","article-title":"Diagnosis of hepatocellular carcinoma","volume":"7","author":"Bialecki","year":"2005","journal-title":"HPB (Oxford)"},{"issue":"19","key":"10.1016\/j.biopha.2017.06.047_bib0025","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1158\/0008-5472.CAN-09-1482","article-title":"Overactivation of the MEK\/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4","volume":"69","author":"Caja","year":"2009","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2017.06.047_bib0030","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jhep.2008.07.021","article-title":"Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity","volume":"49","author":"Carmona-Cuenca","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2017.06.047_bib0035","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1471-2407-9-100","article-title":"Regulation of HSP27 on NF-kappaB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis","volume":"9","author":"Guo","year":"2009","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2017.06.047_bib0040","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1158\/1535-7163.MCT-09-0551","article-title":"Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2","volume":"8","author":"Lim","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"4","key":"10.1016\/j.biopha.2017.06.047_bib0045","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/hep.23051","article-title":"Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells","volume":"50","author":"Malz","year":"2009","journal-title":"Hepatology"},{"issue":"7006","key":"10.1016\/j.biopha.2017.06.047_bib0050","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biopha.2017.06.047_bib0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.biopha.2017.06.047_bib0060","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1872-034X.2009.00502.x","article-title":"Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated","volume":"39","author":"Huang","year":"2009","journal-title":"Hepatol. Res."},{"issue":"3","key":"10.1016\/j.biopha.2017.06.047_bib0065","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2012.04.031","article-title":"MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma","volume":"57","author":"Shih","year":"2012","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2017.06.047_bib0070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ccr.2012.07.023","article-title":"TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma","volume":"22","author":"Yang","year":"2012","journal-title":"Cancer Cell"},{"issue":"24","key":"10.1016\/j.biopha.2017.06.047_bib0075","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1158\/0008-5472.CAN-11-1144","article-title":"miR-221 silencing blocks hepatocellular carcinoma and promotes survival","volume":"71","author":"Park","year":"2011","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2017.06.047_bib0080","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MCG.0b013e3181f18ac2","article-title":"Circulating microRNAs as biomarkers for hepatocellular carcinoma","volume":"45","author":"Qu","year":"2011","journal-title":"J. Clin. Gastroenterol."},{"issue":"5","key":"10.1016\/j.biopha.2017.06.047_bib0085","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1440-1827.2010.02526.x","article-title":"Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development","volume":"60","author":"Shigoka","year":"2010","journal-title":"Pathol. Int."},{"issue":"5","key":"10.1016\/j.biopha.2017.06.047_bib0090","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/carcin\/bgp250","article-title":"miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma","volume":"31","author":"Furuta","year":"2010","journal-title":"Carcinogenesis"},{"issue":"13","key":"10.1016\/j.biopha.2017.06.047_bib0095","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1158\/0008-5472.CAN-06-4607","article-title":"Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma","volume":"67","author":"Gramantieri","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2017.06.047_bib0100","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.biopha.2016.07.037","article-title":"miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6","volume":"83","author":"Zhu","year":"2016","journal-title":"Biomed. Pharmacothe. Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.biopha.2017.06.047_bib0105","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1158\/0008-5472.CAN-08-2886","article-title":"MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity","volume":"69","author":"Su","year":"2009","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.biopha.2017.06.047_bib0110","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/hep.22806","article-title":"MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma","volume":"49","author":"Tsai","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.biopha.2017.06.047_bib0115","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/gut.2011.239145","article-title":"The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2","volume":"61","author":"Zheng","year":"2012","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.biopha.2017.06.047_bib0120","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.cell.2009.04.021","article-title":"Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model","volume":"137","author":"Kota","year":"2009","journal-title":"Cell"},{"issue":"28","key":"10.1016\/j.biopha.2017.06.047_bib0125","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1038\/onc.2011.500","article-title":"MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo","volume":"31","author":"He","year":"2012","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.biopha.2017.06.047_bib0130","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1172\/JCI63539","article-title":"Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver","volume":"122","author":"Hsu","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.biopha.2017.06.047_bib0135","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nbt0713-577","article-title":"First microRNA mimic enters clinic","volume":"31","author":"Bouchie","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"8","key":"10.1016\/j.biopha.2017.06.047_bib0140","doi-asserted-by":"crossref","first-page":"e102602","DOI":"10.1371\/journal.pone.0102602","article-title":"MicroRNA-493 suppresses tumor growth, invasion and metastasis of lung cancer by regulating E2F1","volume":"9","author":"Gu","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2017.06.047_bib0145","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1158\/1535-7163.MCT-11-0592","article-title":"Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4","volume":"11","author":"Ueno","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"10","key":"10.1016\/j.biopha.2017.06.047_bib0150","first-page":"1027","article-title":"MiR-493 suppresses the proliferation and invasion of gastric cancer cells by targeting RhoC","volume":"18","author":"Zhou","year":"2015","journal-title":"Iran J. Basic Med. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2017.06.047_bib0155","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/cas.12380","article-title":"MKK7 mediates miR-493-dependent suppression of liver metastasis of colon cancer cells","volume":"105","author":"Sakai","year":"2014","journal-title":"Cancer Sci."},{"issue":"7","key":"10.1016\/j.biopha.2017.06.047_bib0160","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/emboj.2012.25","article-title":"miR-493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver","volume":"31","author":"Okamoto","year":"2012","journal-title":"EMBO J."},{"issue":"04","key":"10.1016\/j.biopha.2017.06.047_bib0165","first-page":"486","article-title":"MicroRNA-493 inhibited proliferation, migration and tumor formation of breast cancer cell MCF7","author":"Wei","year":"2015","journal-title":"Chin. J. Cell Biol."},{"issue":"12","key":"10.1016\/j.biopha.2017.06.047_bib0170","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1111\/j.1462-5822.2008.01226.x","article-title":"Functional interactions between anthrax toxin receptors and the WNT signalling protein LRP6","volume":"10","author":"Abrami","year":"2008","journal-title":"Cell. Microbiol."},{"issue":"9","key":"10.1016\/j.biopha.2017.06.047_bib0175","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1158\/0008-5472.CAN-14-1327","article-title":"RSPO2 enhances canonical wnt signaling to confer stemness-associated traits to susceptible pancreatic cancer cells","volume":"75","author":"Ilmer","year":"2015","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2017.06.047_bib0180","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1091\/mbc.e08-02-0187","article-title":"R-Spondin family members regulate the Wnt pathway by a common mechanism","volume":"19","author":"Kim","year":"2008","journal-title":"Mol. Biol. Cell"},{"issue":"7","key":"10.1016\/j.biopha.2017.06.047_bib0185","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2893.2009.01117.x","article-title":"Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden","volume":"16","author":"Nguyen","year":"2009","journal-title":"J. Viral Hepat."},{"issue":"46","key":"10.1016\/j.biopha.2017.06.047_bib0190","doi-asserted-by":"crossref","first-page":"13030","DOI":"10.3748\/wjg.v21.i46.13030","article-title":"Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1","volume":"21","author":"Tan","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2017.06.047_bib0195","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3892\/or.2015.4334","article-title":"MicroRNA-616 promotes the migration, invasion and epithelial-mesenchymal transition of HCC by targeting PTEN","volume":"35","author":"Zhang","year":"2016","journal-title":"Oncol. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2017.06.047_bib0200","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.febslet.2014.03.030","article-title":"miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally","volume":"588","author":"Zhang","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2017.06.047_bib0205","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.addr.2014.10.029","article-title":"Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics","volume":"81","author":"Yang","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2017.06.047_bib0210","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.cell.2006.03.007","article-title":"LRP6 holds the key to the entry of anthrax toxin","volume":"124","author":"Bann","year":"2006","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.biopha.2017.06.047_bib0215","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ccr.2012.01.004","article-title":"TEM8\/ANTXR1 blockade inhibits pathological angiogenesis and potentiates tumoricidal responses against multiple cancer types","volume":"21","author":"Chaudhary","year":"2012","journal-title":"Cancer Cell"},{"issue":"18","key":"10.1016\/j.biopha.2017.06.047_bib0220","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1158\/0008-5472.CAN-13-1080","article-title":"ANTXR1, a stem cell-enriched functional biomarker, connects collagen signaling to cancer stem-like cells and metastasis in breast cancer","volume":"73","author":"Chen","year":"2013","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.biopha.2017.06.047_bib0225","doi-asserted-by":"crossref","first-page":"e22334","DOI":"10.1371\/journal.pone.0022334","article-title":"Tumor endothelial marker 8 amplifies canonical Wnt signaling in blood vessels","volume":"6","author":"Verma","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2017.06.047_bib0230","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.cell.2005.12.045","article-title":"The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin","volume":"124","author":"Wei","year":"2006","journal-title":"Cell"},{"issue":"7413","key":"10.1016\/j.biopha.2017.06.047_bib0235","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature11282","article-title":"Recurrent R-spondin fusions in colon cancer","volume":"488","author":"Seshagiri","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2017.06.047_bib0240","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc3419","article-title":"WNT signalling pathways as therapeutic targets in cancer","volume":"13","author":"Anastas","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2017.06.047_bib0245","doi-asserted-by":"crossref","first-page":"140120","DOI":"10.1098\/rsob.140120","article-title":"Wnt signalling induces accumulation of phosphorylated beta-catenin in two distinct cytosolic complexes","volume":"4","author":"Gerlach","year":"2014","journal-title":"Open Biol"},{"issue":"1","key":"10.1016\/j.biopha.2017.06.047_bib0250","first-page":"1","article-title":"Caught up in a Wnt storm: Wnt signaling in cancer","volume":"1653","author":"Giles","year":"2003","journal-title":"Biochim. Biophys."},{"issue":"5","key":"10.1016\/j.biopha.2017.06.047_bib0255","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrc2389","article-title":"Wnt signalling and its impact on development and cancer","volume":"8","author":"Klaus","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2017.06.047_bib0260","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1530-0277.2011.01682.x","article-title":"Ethanol affects differentiation-related pathways and suppresses Wnt signaling protein expression in human neural stem cells","volume":"36","author":"Vangipuram","year":"2012","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.biopha.2017.06.047_bib0265","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-213X-12-21","article-title":"Expression of canonical WNT\/beta-CATENIN signaling components in the developing human lung","volume":"12","author":"Zhang","year":"2012","journal-title":"BMC Dev. Biol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217309319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217309319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:14:29Z","timestamp":1766024069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217309319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":53,"alternative-id":["S0753332217309319"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.06.047","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-493 suppresses hepatocellular carcinoma tumorigenesis through down-regulation of anthrax toxin receptor 1 (ANTXR1) and R-Spondin 2 (RSPO2)","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.06.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}